Evidence map›Paper›PMID 23114783›Full record

ArticleAntimicrobial agents and chemotherapy2013

Cytostatic versus cytocidal activities of chloroquine analogues and inhibition of hemozoin crystal growth.

Alexander P Gorka, John N Alumasa, Katy S Sherlach, Lauren M Jacobs, Katherine B Nickley, Jonathan P Brower, Angel C de Dios, Paul D Roepe

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antimalarial Activity of Small-Molecule Benzothiazole Hydrazones.Antimicrobial agents and chemotherapy · 2016
    Article
  13. Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  14. Review
  15. Article
  16. Article
  17. Malarial hemozoin: from target to tool.Biochimica et biophysica acta · 2014
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alexander P GorkaDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC, USA.
John N Alumasa
Katy S Sherlach
Lauren M Jacobs
Katherine B Nickley
Jonathan P Brower
Angel C de Dios
Paul D Roepe
Georgetown University · US

Funding

THE PHYSIOLOGY OF DRUG RESISTANT MALARIAR01AI045957 · NIAID · GEORGETOWN UNIVERSITY · PI ROEPE, PAUL D. · 2000 to 2009
$1.9M
Designing HTA therapy for drug resistant malariaR01AI060792 · NIAID · GEORGETOWN UNIVERSITY · PI WOLF, CHRISTIAN · 2005 to 2009
$1.9M
NIAID NIH HHS AI045957NIAID NIH HHS AI060792NIAID NIH HHS R01 AI045957NIAID NIH HHS R01 AI060792
6 · The paper itself

Abstract

We report an improved, nonhazardous, high-throughput assay for in vitro quantification of antimalarial drug inhibition of β-hematin (hemozoin) crystallization performed under conditions that are more physiological relative to previous assays. The assay uses the differential detergent solubility of crystalline and noncrystalline forms of heme and is optimized via the use of lipid catalyst. Using this assay, we quantify the effect of pH on the crystal growth-inhibitory activities of current quinoline antimalarials, evaluate the catalytic efficiencies of different lipids, and test for a possible correlation between hemozoin inhibition by drugs versus their antiplasmodial activity. Consistent with several previous reports, we found a good correlation between hemozoin inhibition potency versus cytostatic antiplasmodial potency (50% inhibitory concentration) for a series of chloroquine (CQ) analogues. However, we found no correlation between hemozoin inhibition potency and cytocidal antiplasmodial potency (50% lethal dose) for the same drugs, suggesting that cellular targets for these two layers of 4-aminoquinoline drug activity differ. This important concept is also explored further for QN and its stereoisomers in the accompanying paper (A. P. Gorka, K. S. Sherlach, A. C. de Dios, and P. D. Roepe, Antimicrob. Agents Chemother. 57:365-374, 2013).

Indexed as

AntimalarialsCells, CulturedChloroquineCrystallizationCytostatic AgentsCytotoxinsErythrocytesHemeHemeproteinsHumansInhibitory Concentration 50KineticsPhospholipidsPlasmodium falciparumAntimalarialsChloroquineCytostatic AgentsCytotoxinsHemeHemeproteinshemozoinPhospholipids

Identifiers

PMID23114783
PMCPMC3535939
OpenAlexW2035062424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.